Xeris Biopharma Holdings FY2030 Revenue expected to be more than 1 Billion up from $750M
Benzinga Newsdesk 1 hour ago
NewsGuidance
Xeris Biopharma Holdings (NASDAQ:XERS) FY2030 Revenue expected to be more than 1 Billion up from approximately $750 million.
Xeris Biopharma Holdings (NASDAQ:XERS) FY2030 Revenue expected to be more than 1 Billion up from approximately $750 million.